MAPK6 and breast carcinoma: In one study, ERK3 mRNA and protein levels were upregulated in doxorubicin-resistant MCF-7 breast cancer cells as compared to parental MCF-7 cells, suggesting the involvement of ERK3 in cancer chemoresistance [61].